Profil
Lena Moran-Adams is currently Group General Counsel at Gubra A, starting in 2026.
Formerly, Ms. Moran-Adams was Head-Legal & Business Conduct at Gilead Sciences, Inc. from 2019 to 2021, Global Head-Legal at Novartis AG from 2011 to 2019, and General Counsel at Telix Pharmaceuticals Ltd. Education includes graduate studies at Flinders University.
Aktive Positionen von Lena Moran-Adams
| Unternehmen | Position | Beginn |
|---|---|---|
| GUBRA A/S | General Counsel | 16.06.2026 |
Ehemalige bekannte Positionen von Lena Moran-Adams
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | 01.07.2021 |
| NOVARTIS AG | General Counsel | 01.01.2019 |
| TELIX PHARMACEUTICALS LIMITED | General Counsel | - |
Ausbildung von Lena Moran-Adams
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Flinders University
Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
















